Your fact-checks will appear here
Randomized trials and systematic reviews show penile traction devices (PTDs) can produce measurable length gains—typically about 1.5–2.2 cm over months—and reduce Peyronie’s curvature by roughly 10–25...
Clinical studies show penile traction devices (PTDs) can produce small but measurable length gains in men with Peyronie’s disease, men after prostatectomy, and some small studies in men with shortened...
FDA does clear some penile traction devices for *therapeutic* indications such as treating Peyronie’s disease and restoring length lost after urologic procedures, but the marketplace is full of produc...
Clinical evidence and regulatory guidance show penile traction devices (PTDs) can produce modest, sometimes durable length gains and improve curvature in men with Peyronie’s disease when used consiste...
Randomized trials of modern penile traction therapy (), especially , show consistent, statistically and clinically meaningful improvements in penile length and curvature at 3 months and through short-...
span cervical and lumbar units, motorized systems, traction beds, and niche therapies such as penile traction; claims of efficacy are device- and indication-specific and overall evidence is mixed, wit...
Randomized trials and systematic reviews show penile traction devices (PTDs) can reduce curvature in Peyronie’s disease and in some studies preserve or modestly increase penile length (e.g., +1.6 cm v...
produces reproducible short‑term gains in stretched/erect penile length and modest reductions in curvature, but high‑quality evidence on whether those gains persist at two years or longer is limited a...
Penile traction therapy (PTT) — the medically supervised use of traction devices — is generally described in the literature as tolerable with mostly mild, transient adverse effects in men treated for ...
Long‑term use of penile traction devices (PTDs) is generally reported as well tolerated, with most studies documenting mild, transient side effects such as discomfort, swelling, skin irritation, bruis...
Penile traction devices (PTDs) are non‑surgical tools used mainly to treat Peyronie’s disease (PD) and to limit length loss or erectile dysfunction after prostate surgery; randomized and meta‑analytic...
Sustained adherence to penile traction therapy (PTT) over 12–24 months appears to be driven less by a single demographic trait than by a mix of clinical state, device burden (time/cost), and early pat...
A small set of traction and implant products are commonly marketed for penile stretching or aesthetic enhancement, and several vendors explicitly claim FDA clearance or approval—most notably SizeGenet...
Contemporary evidence shows two clusters of effective penile traction therapy (PTT) protocols: older-generation devices that required multi-hour daily wear (commonly ≥3–5 hours/day for several months)...
Randomized trials demonstrate that modern penile traction therapy () devices can produce modest, reproducible increases in penile length in men with Peyronie’s disease or post‑surgical shortening, but...
No randomized head‑to‑head trials comparing the penile traction device directly against other specific penile traction devices were identified in the provided reporting; published randomized studies o...
-clostridium-histolyticum">Combined penile traction therapy (PTT) added to collagenase (CCH) consistently increases immediate compared with CCH alone across multiple series and reviews, but direct, hi...
Multi‑hour penile traction protocols historically required 3–8 hours daily and produced substantial drop‑off in real‑world use; early studies flagged prolonged wear as a core reason patients did not p...
Randomized trials have mostly tested newer-generation penile traction devices (notably RestoreX and Penimaster PRO) against no‑intervention controls and have also explored shorter daily wear times (30...
A focused review of the supplied literature finds randomized, controlled trials of penile traction therapy (PTT) concentrated in two clinical populations—men with Peyronie’s disease (PD) and men after...